Profil
John Hayslip currently works at Verastem, Inc., as Chief Medical Officer from 2024.
Dr. Hayslip also formerly worked at The Markey Cancer Center Foundation, as Director-Clinical Research & Data Management, Nektar Therapeutics, as Vice President-Clinical Development, and I-Mab, as Chief Medical Officer from 2022 to 2024.
Dr. Hayslip received his graduate degree from The Medical University of South Carolina and doctorate degree from Northeast Ohio Medical University.
Aktiva positioner av John Hayslip
| Företag | Position | Start |
|---|---|---|
| VERASTEM, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2024-04-18 |
Tidigare kända positioner av John Hayslip
| Företag | Position | Slut |
|---|---|---|
| NOVABRIDGE BIOSCIENCES | Teknisk/Vetenskaplig/F&U Direktör | 2024-04-15 |
The Markey Cancer Center Foundation | Företagsledare/Principal | - |
| NEKTAR THERAPEUTICS | Teknisk/Vetenskaplig/F&U Direktör | - |
John Hayslips utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Nektar Therapeutics
Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
Medical University of South Carolina
Medical University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Markey Cancer Center Foundation | |
Verastem, Inc.
Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Northeast Ohio Medical University
Northeast Ohio Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
I-Mab
I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases | Health Technology |
















